Process for preparing fondaparinux sodium and intermediates useful in the synthesis thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8703923
APP PUB NO 20130102764A1
SERIAL NO

13618786

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Processes for the synthesis of the Factor Xa anticoagulent Fondaparinux, and related compounds are described. Also described are protected pentasaccharide intermediates as well as efficient and scalable processes for the industrial scale production of Fondaparinux sodium by conversion of the protected pentasaccharide intermediates via a sequence of deprotection and sulfonation reactions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RELIABLE BIOPHARMACEUTICAL LLCRADNOR CORPORATE CENTER 100 MATSONFORD ROAD BUILDING ONE SUITE 200 RADNOR PA 19087

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Nadji, Sourena Olivette, US 13 82
Smoot, James T Mt. Zion, US 3 8
Vanartsdalen, Joseph A Saint Charles, US 3 8

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 22, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00